56826-69-8 Usage
Description
6,7-Dihydro-5H-quinolin-8-one is a synthetic intermediate that is characterized by its light yellow crystalline appearance. It plays a significant role in the synthesis of various compounds, particularly tetrahydropyridoazepinones and thiosemicarbazones, which have demonstrated anticancer properties.
Uses
Used in Pharmaceutical Industry:
6,7-Dihydro-5H-quinolin-8-one is used as a synthetic intermediate for the development of compounds with potential anticancer activity. Its role in the synthesis of tetrahydropyridoazepinones and thiosemicarbazones makes it a valuable component in the creation of novel therapeutic agents to combat cancer.
Used in Chemical Research:
In the field of chemical research, 6,7-Dihydro-5H-quinolin-8-one serves as a key intermediate for the synthesis of various complex organic molecules. Its unique structure and properties allow researchers to explore new avenues in drug discovery and the development of advanced materials.
Used in Drug Synthesis:
6,7-Dihydro-5H-quinolin-8-one is utilized as a building block in the synthesis of pharmaceutical compounds, particularly those with potential applications in the treatment of cancer. Its versatility in chemical reactions enables the creation of a wide range of therapeutic agents, contributing to the ongoing efforts to develop more effective cancer treatments.
Synthesis Reference(s)
The Journal of Organic Chemistry, 49, p. 2208, 1984 DOI: 10.1021/jo00186a027Synthetic Communications, 33, p. 3497, 2003 DOI: 10.1081/SCC-120024729
Check Digit Verification of cas no
The CAS Registry Mumber 56826-69-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,8,2 and 6 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 56826-69:
(7*5)+(6*6)+(5*8)+(4*2)+(3*6)+(2*6)+(1*9)=158
158 % 10 = 8
So 56826-69-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h2,4,6H,1,3,5H2
56826-69-8Relevant articles and documents
Efficient Pyrazolo[5,4-f]quinoxaline Functionalized Os(II) Based Emitter with an Electroluminescence Peak Maximum at 811 nm
Zhu, Ze-Lin,Wang, Sheng-Fu,Fu, Li-Wen,Tan, Ji-Hua,Cao, Chen,Yuan, Yi,Yiu, Shek-Man,Zhang, Ye-Xin,Chi, Yun,Lee, Chun-Sing
, (2021/12/09)
Upon fusing the pyrazinyl pyrazole entity in giving pyrazolo[3,4-f]quinoxaline chelate, the corresponding Os(II) based NIR emitter exhibited “invisible” and efficient electroluminescence with a peak maximum at 811 nm. A maximum external quantum efficiency
Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1
Catalano, John G.,Gudmundsson, Kristjan S.,Svolto, Angilique,Boggs, Sharon D.,Miller, John F.,Spaltenstein, Andrew,Thomson, Michael,Wheelan, Pat,Minick, Doug J.,Phelps, Dean P.,Jenkinson, Stephen
experimental part, p. 2186 - 2190 (2010/07/05)
Stereorandom and diastereoselective syntheses of a novel 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system are described. Derivatives of all four diastereomers were prepared and isolated in >98% ee. The pure enantiomers were compared in order t
QUINOLYNYLMETHYLIMIDIZOLES AS THERAPEUTIC AGENTS
-
Page/Page column 14; 15, (2008/12/07)
Disclosed herein is a compound of the formula (I):(I).Therapeutic methods, compositions and medicaments related thereto are also disclosed.
